BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32114429)

  • 1. Association of N6-methyladenosine with viruses and virally induced diseases.
    Wu F; Cheng W; Zhao F; Tang M; Diao Y; Xu R
    Front Biosci (Landmark Ed); 2020 Mar; 25(6):1184-1201. PubMed ID: 32114429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of N6-methyladenosine with viruses and related diseases.
    Wu F; Cheng W; Zhao F; Tang M; Diao Y; Xu R
    Virol J; 2019 Nov; 16(1):133. PubMed ID: 31711514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions.
    Imam H; Kim GW; Siddiqui A
    Front Cell Infect Microbiol; 2020; 10():584283. PubMed ID: 33330128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B Virus X Protein Expression Is Tightly Regulated by N6-Methyladenosine Modification of Its mRNA.
    Kim GW; Siddiqui A
    J Virol; 2022 Feb; 96(4):e0165521. PubMed ID: 34851655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physio-pathological effects of m6A modification and its potential contribution to melanoma.
    Liao Y; Han P; Zhang Y; Ni B
    Clin Transl Oncol; 2021 Nov; 23(11):2269-2279. PubMed ID: 34105069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts.
    Imam H; Kim GW; Mir SA; Khan M; Siddiqui A
    PLoS Pathog; 2020 Feb; 16(2):e1008338. PubMed ID: 32059034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory effect of m
    Yu PL; Cao SJ; Wu R; Zhao Q; Yan QG
    J Med Virol; 2021 Nov; 93(11):6100-6115. PubMed ID: 34329499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential.
    Sun Y; Jin D; Zhang Z; Ji H; An X; Zhang Y; Yang C; Sun W; Zhang Y; Duan Y; Kang X; Jiang L; Zhao X; Lian F
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194967. PubMed ID: 37553065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA N6-methyladenosine methylation and skin diseases.
    Yu Y; Lu S; Jin H; Zhu H; Wei X; Zhou T; Zhao M
    Autoimmunity; 2023 Dec; 56(1):2167983. PubMed ID: 36708146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of m6A modification in the biological functions and diseases.
    Jiang X; Liu B; Nie Z; Duan L; Xiong Q; Jin Z; Yang C; Chen Y
    Signal Transduct Target Ther; 2021 Feb; 6(1):74. PubMed ID: 33611339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer.
    Petri BJ; Klinge CM
    J Mol Endocrinol; 2023 Feb; 70(2):. PubMed ID: 36367225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m
    Zhao Y; Shi Y; Shen H; Xie W
    J Hematol Oncol; 2020 Apr; 13(1):35. PubMed ID: 32276589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic Roles of m6A Modification in Viral Infection and Virus-driven Carcinogenesis.
    Wang JF; Cai W; Qiu FS; Yu CH
    Endocr Metab Immune Disord Drug Targets; 2022; 22(10):1009-1017. PubMed ID: 35418293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-methyladenosine modification and the YTHDF2 reader protein play cell type specific roles in lytic viral gene expression during Kaposi's sarcoma-associated herpesvirus infection.
    Hesser CR; Karijolich J; Dominissini D; He C; Glaunsinger BA
    PLoS Pathog; 2018 Apr; 14(4):e1006995. PubMed ID: 29659627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of N6-methyladenosine modification in the life cycle and disease pathogenesis of hepatitis B and C viruses.
    Kim GW; Siddiqui A
    Exp Mol Med; 2021 Mar; 53(3):339-345. PubMed ID: 33742132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
    Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
    J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of mRNA N6-methyladenosine modifications in mammalian gametogenesis.
    Fang F; Wang X; Li Z; Ni K; Xiong C
    Mol Hum Reprod; 2021 May; 27(5):. PubMed ID: 33823008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.
    Wang Q; Liang Y; Luo X; Liu Y; Zhang X; Gao L
    Exp Neurol; 2021 Nov; 345():113829. PubMed ID: 34339678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of N6-methyladenosine modification in the development of Parkinson's disease.
    Zhou J; Han Y; Hou R
    Front Cell Dev Biol; 2023; 11():1321995. PubMed ID: 38155838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.